Animal Science/Pre-veterinary Medicine Accepted Students Live Chat – Video

Posted on by


Animal Science/Pre-veterinary Medicine Accepted Students Live Chat
Animal Science/Pre-veterinary Medicine Accepted Students Live Chat We #39;ll discuss your next steps in the admission process as an accepted student and answer ...

By: Admissions - The University of Findlay

Go here to see the original:

Animal Science/Pre-veterinary Medicine Accepted Students Live Chat - Video

Synbiotic May Help Treat Non Alcoholic Fatty Liver Disease a New Study Finds – Video

Posted on by


Synbiotic May Help Treat Non Alcoholic Fatty Liver Disease a New Study Finds
Please like, subscribe, comment and share! ARTICLE http://ajcn.nutrition.org/content/early/2014/01/08/ajcn.113.068890.short?rss=1 Per the authors, "The objec...

By: Lifestyle Medicine

See the original post here:

Synbiotic May Help Treat Non Alcoholic Fatty Liver Disease a New Study Finds - Video

$3.25 Million Gift Creates Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

Posted on by

Contact Information

Available for logged-in reporters only

Newswise PHILADELPHIA Three longtime allies have joined forces to create the new Penn Medicine/CHOP Friedreichs Ataxia Center of Excellence. The establishment of the center was catalyzed by a $3.25 million gift from the Friedreichs Ataxia Research Alliance (FARA), in partnership with the Hamilton and Finneran families.

For the past 16 years Penn Medicine, The Childrens Hospital of Philadelphia (CHOP), and FARA, a nonprofit organization dedicated to curing FA, have collaborated to provide and push forward the care needed by FA patients.

Friedreichs ataxia (FA) is a rare, progressive neurogenetic condition found in approximately 1 in 50,000 people worldwide. While it is relatively rare, it is the most common form of inherited ataxia, a condition characterized by progressive lack of coordinated movement and loss of balance. FA also involves degeneration of heart muscle and nerve cells. Onset of symptoms usually occurs in childhood, and most patients are confined to a wheelchair by their mid-to-late twenties. Myocardial failure and/or arrhythmias are the most common cause of premature death. Currently there are no approved drugs to treat FA.

FARA, CHOP, and Penn Medicine have also shared in research and clinical trials that have elucidated the metabolic dysfunction underlying FA. Their work has created a database of well-documented patients and a pipeline of more than 20 drug candidates ready to be mined for new therapies. Today the FA clinical program at CHOP is the largest in the world.

Nothing is more rewarding than seeing science at work in the service of the patients and families who suffer from rare diseases such as Friedreichs ataxia, says Glen N. Gaulton, PhD, executive vice dean and chief scientific officer at the Perelman School of Medicine at the University of Pennsylvania. Penn and CHOP are fortunate to support many faculty who dedicate their careers to the care of patients with and research on such rare diseases as FA. Funding for rare disease research is a constant challenge. We are thankful to the donors for this generous gift that significantly enhances our ability to make progress toward new biomarkers, drugs and hopefully, in time, therapies for FA.

The new Centers team is working with pharmaceutical industry partners to develop drug candidates as well as biomarkers for FA, and this effort fits alongside a broader initiative at Penn Medicine: a gift from an anonymous donor recently founded the Center for Orphan Disease Research and Therapy to support the pursuit of novel therapies for rare diseases of all kinds.

Integrating cardiac expertise into the care of patients is one major step forward this gift allows us to pursue, says Philip R. Johnson, MD, executive vice president and chief scientific officer at CHOP. Rare diseases are often an area where philanthropy can make a difference, and the generosity of these donors will make a significant impact.

The Friedreichs Ataxia Center of Excellence is co-directed by David Lynch, MD, PhD, FA program director at CHOP, and Robert B. Wilson, MD, PhD, professor of Pathology and Laboratory Medicine at the Perelman School of Medicine. Lynch and Wilson both serve on FARAs Scientific Advisory Board, and Wilson was a founding member of FARAs board of directors and first chairman of its Scientific Review Committee. Wilson has completed a high-throughput drug screen of more than 340,000 compounds for FA drug discovery and is now working with medicinal chemists to narrow in on candidates for clinical trials.

Read more from the original source:

$3.25 Million Gift Creates Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

Does your undergrad school matter for med school? | TopTestPrep.com – Video

Posted on by


Does your undergrad school matter for med school? | TopTestPrep.com
http://toptestprep.com/admissions-counseling/medical-schools/overview/ | Learn more about how your undergraduate school may affect your medical school applic...

By: Top Test Prep | #1 Tutors and Expert Admissions

Read this article:

Does your undergrad school matter for med school? | TopTestPrep.com - Video

Best Tips for Med School Letters of Recommendation? | TopTestPrep.com – Video

Posted on by


Best Tips for Med School Letters of Recommendation? | TopTestPrep.com
http://toptestprep.com/admissions-counseling/medical-schools/overview/ | Learn more about the people who should write your letters of recommendation for medi...

By: Top Test Prep | #1 Tutors and Expert Admissions

Read this article:

Best Tips for Med School Letters of Recommendation? | TopTestPrep.com - Video

Extracurriculars for your med school application | TopTestPrep.com – Video

Posted on by


Extracurriculars for your med school application | TopTestPrep.com
http://toptestprep.com/admissions-counseling/medical-schools/overview/ Learn more about how your extracurriculars may be the extra boost your medical school ...

By: Top Test Prep | #1 Tutors and Expert Admissions

Read more here:

Extracurriculars for your med school application | TopTestPrep.com - Video

Mini-Medical School series starts Saturday

Posted on by

A Mini-Medical School: Aging with Vitality series kicks off Saturday with keynote speaker Dr. Steven Stricker, physician in chief of Kaiser Permanente.

Stricker was personally requested for this session due to the popularity of his keynote address last year. He approaches the topic of aging with humor, insight and an adept skillfulness.

The Mini-Medical School is a 4-week series covering a variety of topics related to aging with vitality. The topics are presented by local doctors from North Bay, Kaiser Permanente, and Sutter Health.

Classes are held from 9:30 a.m. to 1 p.m. at the Kroc Center, 586 E. Wigeon Way in Suisun City. Lunch is provided.

Class dates and topics are:

* March 8 - Aging with Vitality; Keep the Rhythm Going

* March 15 - Eyesight and Aging; Happiness: Social, Emotional and Psychological Well-being

* March 22 - Neurology: Keeping Your Brain Healthy; Preventing and Managing Chronic Conditions

* March 29 - Women's Health and Aging; Men's Health and Aging

For more information or to register contact Rochelle Sherlock of the Senior Coalition of Solano County at 864-3984.

View post:

Mini-Medical School series starts Saturday

First phase of medical school construction awarded to LP Ciminelli

Posted on by

The SUNY Construction Fund has awarded LP Ciminelli the bid for the first phase of construction for UBs new School of Medicine and Biomedical Sciences building at Main and High streets on the Buffalo Niagara Medical Campus.

The eight-story, 540,000-square-foot building is the first project to receive NYSUNY Challenge Grant funding provided by Gov. Andrew M. Cuomo when he signed the NYSUNY 2020 bill into law in 2011. Construction of the $375 million medical school, scheduled to open in the fall of 2016, will be funded by private philanthropy and state support.

The new medical school will help the university achieve objectives essential to the UB 2020 strategic plan to advance UBs distinction and prominence among the worlds foremost research universities.These objectives include creation of a world-class medical school; recruitment of outstanding researchers, students, clinicians and physician-scientists to the university; and transformation of the region into a major destination for innovative medical care, medical education and research.

The first phase of construction involves excavation, support of excavation, foundations and structural steel, including complete frame-up. The contract is worth approximately $52.05 million. LP Ciminelli was the lowest bidder among three bids.

According to the SUNY Construction Fund, LP Ciminelli has an approved MWBE (minority- and women-owned business enterprises) Utilization Plan for the UB medical school project that is expected to reach 13.2 percent minority-owned and 12.3 percent women-owned, exceeding SUNYs goals of 12 percent minority-owned and 10 percent women-owned, and federal goals of 5 percent for each category.

MWBE participation in major UB construction projects has been significant, and has typically exceeded SUNYs goals, according to officials with UB Facilities, Planning and Design.

The SUNY Construction Fund is the legal entity holding contracts in this project, reviewing bids and providing project funding. UB is partnering with the SUNY Construction Fund in an active, supporting role.

It is expected the second phase of the project will be put out to bid in late spring, with a contractor chosen by fall. The second phase will consist of faade, roof, completion of interior, all plumbing, and mechanical and electrical systems. Phase three will consist of FF and E, meaning furniture, fixtures and equipment, including state-of-the-art medical equipment for labs and other facilities.

See the original post here:

First phase of medical school construction awarded to LP Ciminelli